secwatch.observer — SEC 8-K summary
======================================

Issuer:     Spero Therapeutics, Inc. (SPRO)
CIK:        0001701108
Form:       8-K
Filed at:   2023-10-10T23:59:59+00:00
Accession:  0001193125-23-253136
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Spero Therapeutics stockholders approve 2.5M share increase to 2017 Plan and charter amendments
--------------------------------------------------------------------------------

- Stockholders approved amendment to 2017 Stock Incentive Plan, increasing authorized shares by 2,500,000.
- Charter amendment adding officer exculpation and federal forum selection clause approved and filed with Delaware on Oct 6.
- All three Class III director nominees re-elected: Deshpande, Mahadevia, Tregoning with support from majority of votes cast.
- Advisory vote on executive compensation approved; frequency set to annual.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1701108/000119312523253136/0001193125-23-253136-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1701108/000119312523253136/d570930d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-253136

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer